echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Brit J Cancer: Anti-Acid Drugs and Colorectal Cancer Risk

    Brit J Cancer: Anti-Acid Drugs and Colorectal Cancer Risk

    • Last Update: 2020-06-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Although there are some reasonable biological mechanisms associated with the development of proton pump inhibitors (PPI) and H2 receptor antagonists (H2RAs) with colorectal tumors, their association withcolorectal cancer(CRC) risk has not been fully assessed in prospective epidemiological studies, researchers assessed the relationship between acid-suppressing drug use and CRC risk in 175,871 (PPI) and 208,831 (H2RA) participants from three large prospective cohort sishesesDrug use was assessed at baseline and updated every two yearsThe researchers evaluated the association using a multicox proportional risk regression modelthere is no significant correlation between baseline PPI use (risk ratio (HR) , 95% confidence interval (CI) 0.71-1.12) or after 8-10 years of delay (HR-1.12, 95% CI 0.78-1.59) and CRC riskThe researchers observed no significant correlation between 8-10 years after use of H2RA and CRC risk (HR s 1.02, 95% CI was 0.81-1.28), while baseline H2RA users had a lower risk (HR-0.76, 95% CI was 0.60-0.95)The duration of the use of PPI or H2RA is independent of CRC risk (trend P.21 and 0.95), it is not associated with a higher risk of colorectal cancer using PPI or H2RA
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.